NearWave Analysis: $1M Raised
What is NearWave?
NearWave builds the NearWave Scanner, a handheld frequency domain near infrared spectroscopy device for non-invasive deep tissue measurement. The system uses fdNIRS to quantify tissue optical properties and biomarkers such as regional oxygen saturation and hemoglobin concentrations. It pairs with an iOS app that displays real-time one-dimensional and two-dimensional quantitative mapping data, and the company says the device is for research and investigational use only.
Location
Austin, United States
Employees
1-10
Founded
2022
Revenue
$0-968K
Product Features & Capabilities
- NearWave Scanner, non-invasive device, frequency domain near infrared spectroscopy (fdNIRS), measures tissue oxygenation, assesses StO2, HHb, HbO2, and THb, applicable in sports medicine, weight loss, cardiovascular health assessment.
How much NearWave raised
s for NearWave: - $1.2 million
Not specifiedLead Investor: Not specified
Who are the founders of NearWave
RS
Market Focus
NearWave primarily focuses on the healthcare industry, specifically in the field of medical technology. They develop non-invasive devices that utilize frequency domain near infrared spectroscopy (fdNIRS) to assess vital biomarkers, such as tissue oxygen saturation and hemoglobin concentrations.
Investors
- Y Combinator
- CANCER FUND
- Tampa Bay Wave
- Flywheel Fund
- IrishAngels
- VentureSouq
Competitors Overview
The main competitors of NearWave in the non-invasive medical device market, particularly in the field of frequency domain near infrared spectroscopy (fdNIRS), include:
-
Artinis Medical Systems:
- Overview: Artinis specializes in (f)NIRS devices and has been providing solutions for over two decades. They offer a range of products that include various modalities and supporting features like EEG and tES.
- Advantages: Artinis is known for its user-friendly and high-tech solutions, which may appeal to clinical and research settings. Their devices are designed for ease of use and portability, making them suitable for diverse applications.
-
Soterix Medical Inc.:
- Overview: Soterix Medical focuses on non-invasive brain stimulation and monitoring technologies, including (f)NIRS.
- Advantages: They offer advanced technologies for brain monitoring and stimulation, which may provide unique insights into brain activity and health.
-
NIRx Medical Technologies:
- Overview: NIRx develops and manufactures (f)NIRS systems for both clinical and research applications.
- Advantages: Their systems are designed for high performance and flexibility, allowing for a wide range of applications in brain research and clinical diagnostics.
-
Cortivision:
- Overview: Cortivision provides (f)NIRS devices that are used for brain imaging and monitoring.
- Advantages: Their products are noted for their innovative design and integration capabilities with other monitoring systems.
Notable differences among these competitors include the specific applications of their technologies, the range of features offered, and their target markets (clinical vs. research). NearWave's focus on assessing vital biomarkers like tissue oxygen saturation and hemoglobin concentrations may differentiate it from competitors that focus more on brain monitoring or stimulation.
See something that needs updating? Suggest edits to this profile.